ANCN: Anchiano Therapeutics Ltd. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Anchiano Therapeutics Ltd.

NASDAQ:ANCN

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$75.36
Loss Chance
58.0%
1.14JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
AbbVie
NYSE:ABBV
6.05
$213.76
116.48%
Alexion Pharmaceuticals
NASDAQ:ALXN
6.89
$182.50
52.20%
Biogen
NASDAQ:BIIB
5.83
$190.56
10.72%
Emergent BioSolutions
NYSE:EBS
3.64
$8.06
84.28%
Gilead Sciences
NASDAQ:GILD
6.77
$130.50
0.68%
Jitta Factors
Growth Opportunity (12)
Recent Business Performance (33)
Financial Strength (38)
Return to Shareholders (0)
Competitive Advantage (7)
Jitta Signs
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 65.45% in the last quarter (yoy)
CapExVery High
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
1.14
100.00%
1.98
317.77%
1.98
317.77%
6.89
52.20%
COMPANY DESCRIPTION
As of March 16, 2021, Anchiano Therapeutics Ltd. was acquired by ChemomAb Ltd., in a reverse merger transaction. Anchiano Therapeutics Ltd., a preclinical biotechnology company, discovers, develops, and commercializes small molecule anti-cancer therapeutics. It primarily develops Pan-RAS Program that identifies novel indene-based small molecules that exhibit potent and selective inhibition of activated RAS signaling regardless of isoform or mutation; and PDE10/ß-catenin program, which identifies small molecules that selectively and potently inhibit PDE10 and suppress Wnt/APC/ß-catenin signaling in preclinical models. Anchiano Therapeutics Ltd. has collaboration and license agreement with ADT Pharmaceuticals, LLC to research and develop programs related to the pan-RAS and PDE10/ß-catenin programs. The company was formerly known as BioCancell Ltd. and changed its name Anchiano Therapeutics Ltd. in July 2018. Anchiano Therapeutics Ltd. was founded in 2004 and is headquartered in Cambridge, Massachusetts.
www.anchiano.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.